Hualan Vac
30120717.671.67% ( +0.29 )
Hualan Vac (301207)
Hualan Biological Vaccine Inc. engages in the research and development, production, and sale of vaccines and genetically engineered biological products in China...
- Open
- 17.25
- High
- 17.67
- Low
- 17.21
- Prev. Close
- 17.38
- Volume
- 45.39K
- Turnover
- 79.67M
- Avg Price
- 17.55
- Bid/Ask Ratio
- --
- Amplitude
- 2.65%
- 52wk High
- 27.09
- Volume Ratio
- 0.63
- Turnover Ratio
- 0.76%
Hualan Vac Analyst Rating
View MoreForecast & Rating
Apr 12, 2026Price forecast
¥26.8451.90%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Wallstreetcn · Jan 27 at 04:29 AM
Hualan Vac: The industry in which the company operates is the human vaccine manufacturing industry, with the main product being the quadrivalent influenza virus vaccine, which is used to prevent influenza caused by the influenza virus. Currently, the company does not have any vaccine products for the prevention of Nipah virus
- Zhitong · Nov 3, 2025 at 11:44 PM
Afternoon flu concept shows partial fluctuations, Hualan Vac rises over 10%
- Zhitong · Oct 29, 2025 at 05:47 AM
Hualan Vac released its performance for the first three quarters, with a net profit attributable to the parent company of 132 million yuan, a decrease of 50.51%
- Zhitong · Oct 23, 2025 at 06:54 PM
Overview of A-share dividends and stock distributions: 9 stocks have their equity registration today
- Zhitong · Aug 17, 2025 at 08:02 PM
Overview of the lifting of restrictions on the circulation of A-shares | August 18
- Zhitong · Aug 17, 2025 at 06:34 PM
Overview of A-share lock-up stock release: Lock-up stocks worth 46.718 billion yuan are released today
